Results 101 to 110 of about 4,280 (166)

NKG2A-mediated immune modulation of natural killer cells by Staphylococcus aureus. [PDF]

J Immunol
Davies K, Rizek AM, Edkins S, Kollnberger S, Wang ECY, Eberl M, Underwood J, McLaren JE.   +7 more
europepmc   +1 more source

Herpesvirus-host interactions in neurological diseases: the immunogenetic role of HLA-E. [PDF]

J Virol
Graninger M, Puchhammer-Stöckl E, Vietzen H.   +2 more
europepmc   +1 more source

Distinct NK Cell Genetic Variants Are Associated With HSV-2 Versus VZV Infection of the CNS. [PDF]

J Med Virol
Graninger M, Kühner LM, Berger SM, Vietzen H, Puchhammer-Stöckl E.   +4 more
europepmc   +1 more source

HLA-E single-chain trimer shields gene-edited allogeneic CAR T cells from NK cell attack. [PDF]

Blood Adv
Apodaca KM, Xu C, Stanton KL, Baroja ML, Alfaro Doblado AR, Engel NW, Wellhausen N, Cox A, Berjis A, Ji M, Bushara O, Perez DM, Welch C, Banerjee E, Assenmacher CA, Sheppard NC, Scholler J, June CH, Carreno BM, Linette GP.   +19 more
europepmc   +1 more source

OMIP‐039: Detection and analysis of human adaptive NKG2C⁺ natural killer cells [PDF]

Cytometry Part A, 2017
Quirin, Hammer, Chiara, Romagnani
openaire   +2 more sources

Discovery and preclinical evaluation of monoclonal antibodies and bispecific engagers targeting the NKG2A inhibitory receptor. [PDF]

Sci Adv
Shin S, Kim YJ, Macatangay BJC, Cyktor JC, Hines MG, Sun ZY, Chen K, Mellors JW, Dimitrov DS, Li W, Baek DS.   +10 more
europepmc   +1 more source

Allogeneic CD3- CD19- CD57 NKG2C NK Cells FATE-NK100 [PDF]

, 2020
openaire   +1 more source

iPSCs derived sEVs ameliorate NK cell senescence by targeting CISH-STAT3. [PDF]

Stem Cell Res Ther
Chen Y, Cao R, Chen Z, Zhang J, Ren Y, Niu X, Yuan J, Luo L, Yu S, Wang Y, Li Q.   +10 more
europepmc   +1 more source

Genetic Variability in NKG2 Receptors and Their Ligands: Associations with SARS-CoV-2 Infection and COVID-19 Severity. [PDF]

Genes (Basel)
Siemaszko J, Grad K, Świerkot J, Bogunia-Kubik K.   +3 more
europepmc   +1 more source

Transcriptional Profile Change of NK-92 Cells in Presence of Cytokines, TGFβ Signaling Pathway Inhibitor and CDK7/12/13 Kinase Inhibitor. [PDF]

Int J Mol Sci
Mikhailova V, Marko O, Mkrtchyan E, Sokolov D.   +3 more
europepmc   +1 more source